Matarin Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-33,763
| Closed | -$1.78M | – | 222 |
|
|
2020
Q3 | $1.78M | Buy |
33,763
+23,252
| +221% | +$1.23M | 0.37% | 108 |
|
|
2020
Q2 | $644K | Buy |
+10,511
| New | +$644K | 0.13% | 168 |
|
|
2020
Q1 | – | Sell |
-18,991
| Closed | -$1.08M | – | 260 |
|
|
2019
Q4 | $1.08M | Sell |
18,991
-18,400
| -49% | -$1.05M | 0.1% | 180 |
|
|
2019
Q3 | $2M | Sell |
37,391
-40,944
| -52% | -$2.19M | 0.15% | 171 |
|
|
2019
Q2 | $4.68M | Buy |
78,335
+8,371
| +12% | +$500K | 0.33% | 113 |
|
|
2019
Q1 | $4.36M | Buy |
69,964
+42,969
| +159% | +$2.68M | 0.32% | 114 |
|
|
2018
Q4 | $1.64M | Buy |
26,995
+4,359
| +19% | +$264K | 0.13% | 178 |
|
|
2018
Q3 | $1.32M | Buy |
22,636
+2,278
| +11% | +$133K | 0.09% | 198 |
|
|
2018
Q2 | $913K | Sell |
20,358
-13,422
| -40% | -$602K | 0.07% | 213 |
|
|
2018
Q1 | $1.5M | Sell |
33,780
-15,172
| -31% | -$673K | 0.11% | 188 |
|
|
2017
Q4 | $2.12M | Sell |
48,952
-10,125
| -17% | -$439K | 0.17% | 168 |
|
|
2017
Q3 | $2.75M | Buy |
59,077
+2,043
| +4% | +$95K | 0.23% | 157 |
|
|
2017
Q2 | $2.82M | Sell |
57,034
-2,244
| -4% | -$111K | 0.26% | 142 |
|
|
2017
Q1 | $3.25M | Buy |
59,278
+11,817
| +25% | +$648K | 0.32% | 129 |
|
|
2016
Q4 | $2.64M | Buy |
47,461
+30,088
| +173% | +$1.68M | 0.3% | 136 |
|
|
2016
Q3 | $793K | Sell |
17,373
-6,152
| -26% | -$281K | 0.09% | 189 |
|
|
2016
Q2 | $940K | Sell |
23,525
-692
| -3% | -$27.6K | 0.13% | 178 |
|
|
2016
Q1 | $843K | Buy |
24,217
+17,738
| +274% | +$618K | 0.12% | 185 |
|
|
2015
Q4 | $278K | Buy |
+6,479
| New | +$278K | 0.04% | 207 |
|